Product Information
GUANFACINE HCL ER 3 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1660 per EA under NDC 70436004101. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on Nov 25, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436004101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213428FDA Approved
11/25/2020
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GUANFACINE HCL ER 3 MG TABLET has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1660 per EA |
|---|---|
| All-time high | $0.2554 (Mar 15, 2023) |
| All-time low | $0.1520 (Nov 20, 2024) |
| 52-week high | $0.2020 |
| 52-week low | $0.1636 |
| Median price | $0.1916 |
| Average price | $0.2004 |
| Largest weekly change | +43.0% (Jun 19, 2024) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GUANFACINE HCL ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUANFACINE HCL ER 3 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1660 per EA (NDC 70436004101), effective Aug 19, 2026.
How has the price of GUANFACINE HCL ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUANFACINE HCL ER 3 MG TABLET has declined 34.7%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for GUANFACINE HCL ER 3 MG TABLET?
Since Nov 9, 2022, the NADAC for GUANFACINE HCL ER 3 MG TABLET has ranged from a low of $0.1520 (Nov 20, 2024) to a high of $0.2554 (Mar 15, 2023), with a median of $0.1916 per EA.
Are there cheaper alternatives to GUANFACINE HCL ER 3 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GUANFACINE HCL ER 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GUANFACINE HCL ER 3 MG TABLET?
GUANFACINE HCL ER 3 MG TABLET (NDC 70436004101) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.